bluuebunny/crossref_metadata_2025_split huggingface dataset:
Impact of early PCSK9 inhibitor treatment on heart after percutaneous coronary intervention in patients with STEMI: Design and rationale of the PERFECT II trial
Authors: Xia Jiachun , Wang Xinyue , Zhou Jun , Wang Dong , Pang Yanan , Xu Xin , Sang Zhenchi , Zhang Yi , Zhang Junfeng , Wu Sicheng , Xiao Zhengguang , Hou Lei 
Published: September 2022

Background and aimsPrimary percutaneous coronary intervention (PPCI) is the most effective treatment strategy for ST-segment elevation myocardial infarction (STEMI). Nevertheless, dysregulated inflammation induced by myocardial reperfusion injury may increase the final infarct size and induce maladaptive myocardial remodeling. Proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitor, as a novel and potent lipid-lowering drug, plays an important role in inflammation. The aim of this study is to investigate whether the early application of PCSK9 inhibitor can increase the myocardial salvage index (MSI) and improve ventricular remodeling in patients with STEMI.DesignThe PERFECT II trial is a prospective, open-label, multicenter, randomized controlled study involving 160 patients with STEMI who are scheduled to undergo PPCI. The eligible patients will be divided into PCSK9 inhibitor group and control group via the interactive web response system, at a 1:1 ratio. In the PCSK9 inhibitor group, the PCSK9 inhibitor alirocumab at a dose of 75 mg will be subcutaneously injected immediately after PPCI and administered every 2 weeks thereafter for 3 months based on conventional treatment. In the control group, conventional treatment will be administered. The primary endpoint is MSI, as measured by cardiac magnetic resonance imaging (CMR) at 1 week after PPCI. The secondary endpoints are the peak time of creatine kinase (CK)-MB and troponin I (TnI)/TnT after PPCI; the postoperative fall time of the ST segment on electrocardiography (ECG); the rate of plasma low-density lipoprotein cholesterol (LDL-C) compliance (&lt; 1.4 mmol/L and a reduction of &gt;50% from baseline) at 1, 3, and 6 months after PPCI; infarct size and ejection fraction (EF) measured by CMR at 6 months after PPCI; the occurrence of major adverse cardiovascular event (MACE: a composite of cardiovascular death, non-fatal myocardial infarction, stent thrombosis, repeat revascularization, stroke, and heart failure needed to be hospitalized).ConclusionsThis is the first multicenter study to investigate the effect of early application of the PCSK9 inhibitor alirocumab on MSI in patients with STEMI undergoing PPCI. The findings will provide an opportunity to explore novel ideas and methods for the treatment of acute myocardial infarction.Trial registrationClinicalTrials.gov, identifier: NCT05292404.
Higher Blood Cadmium Concentration Is Associated With Increased Likelihood of Abdominal Aortic Calcification
Authors: Qin Zheng , Liu Qiang , Jiao Pengcheng , Geng Jiwen , Liao Ruoxi , Su Baihai 
Published: September 2022

AimsThis study aimed to evaluate the association between blood cadmium concentration (BCC) and abdominal aortic calcification (AAC) in adults aged ≥40 years in the United States.MethodsData were obtained from the 2013–2014 National Health and Nutrition Examination Survey (NHANES). Participants without data about BCC and AAC scores were excluded. BCC was directly measured using inductively coupled plasma mass spectrometry (ICP–MS). AAC scores were quantified by the Kauppila scoring system, and severe AAC was defined as an AAC score &gt;6. Weighted multivariable regression analysis and subgroup analysis were conducted to explore the independent relationship between cadmium exposure with AAC scores and severe AAC.ResultsA total of 1,530 participants were included with an average BCC of 0.47 ± 0.02 μg/L and AAC score of 1.40 ± 0.10 [mean ± standard error (SE)]. The prevalence of severe AAC was 7.96% in the whole subjects and increased with the higher BCC tertiles (Tertile 1: 4.74%, Tertile 2: 9.83%, and Tertile 3: 10.17%; p = 0.0395). We observed a significant positive association between BCC and the AAC score (β = 0.16, 95% CI: 0.01~0.30) and an increased risk of severe AAC [odds ratio (OR) = 1.45; 95% CI: 1.03~2.04]. Subgroup analysis and interaction tests revealed that there was no dependence for the association between BCC and AAC.ConclusionBlood cadmium concentration was associated with a higher AAC score and an increased likelihood of severe AAC in adults in the United States. Cadmium exposure is a risk factor for AAC, and attention should be given to the management of blood cadmium.
Which cardiac parameters best predict the cardiovascular outcomes among patients with anti-PD-1 immunotherapy-induced myocardial injury?
Authors: Peng Xiongjun , Zheng Yawen , Zhu Zhaowei , Liu Na , Zhou Shenghua , Long Junke 
Published: September 2022

AimTo explore the association of cardiac parameters with different clinical outcomes in patients with anti-PD-1 immunotherapy-induced myocardial injury.Methods and resultsWe screened 3,848 patients who received anti-PD-1 immunotherapy from June 2018 to Oct 2021 at the Second Xiangya Hospital of Central South University. Among those patients, 134 patients were diagnosed with anti-PD-1 immunotherapy-induced myocardial injury. Twenty-four patients with cardiovascular symptoms were divided into the major adverse cardiac events (MACE) group, and 110 patients without cardiovascular symptoms were divided into the non-MACE group. We compared creatine kinase isozyme (CK-MB), high-sensitivity troponin T (hsTNT), N-terminal pro–B-type natriuretic peptide (NT-ProBNP), electrocardiography (ECG), and echocardiographic parameters between the two groups of patients. CK-MB, hsTNT, NT-proBNP [2,600.0 (1,317.00–7,950.00) vs. 472.9 (280.40–788.80), p ≤ 0.001], left ventricular end-diastolic diameter (LVEDd), left ventricular ejection fraction (LVEF) and QRS interval were significantly different. The receiver operating characteristic (ROC) curve was used to compare the accuracy of various indicators to predict the occurrence of MACE events. NT-ProBNP (area under the curve [AUC] 97.1) was the best predictor, followed by CK-MB (AUC = 94.1), LVEF (AUC = 83.4), LVEDd (AUC = 81.5), and other indicators. In the MACE group, 11/24 patients had experienced cardiogenic death by the end of follow-up. There were significant differences in the CK-MB, hsTNT, NT-proBNP, LVEDd, LVEF, and QRS intervals between the deceased patients and the survivors. The ROC curve shows that hsTNT is the most accurate marker for predicting cardiogenic death in the MACE group (AUC = 91.6).ConclusionIn patients with myocardial injury after PD-1 inhibitor treatment, NT-proBNP is the parameter of choice to predict the likelihood of developing cardiovascular symptoms, whereas, in symptomatic patients, hsTNT is the optimal parameter associated with the outcome of death compared with other cardiac parameters.
Pore structure characterization for coal measure shales of the Xiashihezi Formation in the Sunan Syncline block, southern North China basin
Authors: Wang Qian , Su Xianbo , Jin Yi , Chen Peihong , Zhao Weizhong , Yu Shiyao 
Published: September 2022

To characterize the coal measure shale pore structure of the Xiashihezi Formation in the Sunan Syncline block, a series of experiments were conducted. Results show that the main components of the shales are clay minerals and quartz, and organic matter, fluid escaping, interlayer, intercrystalline and interparticle pores are well-developed. The shale pore specific surface area (SSA) is concentrated in the pores with the size of &lt;50 nm and is significantly higher in the pores with the size of &lt; 5 nm, indicating that these pores have an important effect on gas adsorption. The shale pore volume is mainly concentrated near the pore size of 10 nm, followed by 10,000–100,000 nm, indicating that in addition to the fractures, the matrix pores with a size of about 10 nm contribute the most to pore volume and free gas accumulation. The volume and SSA of the micropore, small pore, and mesopore increase with the TOC content when it is lower than 6%, leading to higher porosity and total pore SSA of the shales. However, this positive correlation disappears under the compaction effect when the TOC content is higher than 6%. The clay mineral content has negative correlations with the volume and SSA of the mesopore and macropore under the compaction and pore blockage effects, but it correlates poorly with those of the micropore and small pore, causing a decrease in the shale porosity as it increases, while the brittle mineral can promote mesopore and macropore development and is conducive to micropore and small pore maintenance when its content is higher than 45%. As a result, the shale porosity tends to increase with the brittle mineral content. This study is helpful in clarifying the coal measure shale gas enrichment law in the block and in providing fundamental support for coal measure gas efficient development.
Research on the gas migration trend and mechanism of the transition flow regime in coal based on MRT-LBM simulation
Authors: Liu Yanwei , Jia Haojie , Han Hongkai , Zuo Weiqin , Shi Jin , Chang Ping , Miao Jian , He Yanyan , Peng Jie 
Published: September 2022

In order to reveal the process and mechanism of gas flow in a low-permeability coal seam, a new multiple-relaxation-time lattice Boltzmann method (MRT-LBM) model of gas migration in coal micro/nanopores based on Langmuir monolayer adsorption theory, the slip boundary scheme and Bosanquet effective viscosity was established. The software MATLAB was used to carry out the simulation study of uniform pore gas flow based on the MRT-LBM model, and the results were compared and verified with the porous anodic alumina membrane gas flow experimental results. On this basis, the gas flow in coal pores with different micro/nanopore sizes considering adsorption was simulated. The results show that the dimensionless permeability coefficient increases with decreasing pore size under the same pressure, which reflects the subsequent enhancement of the microboundary constraint effect and reveals that the pore system becomes the main controlling factor of coal seam permeability within the coal matrix in the middle and late stages of coal seam gas extraction, while the role of the microboundary constraint effect needs to be considered. The gas adsorption layer weakens the pore gas flow capacity, but for pores with a radius greater than 16 nm, the apparent change in permeability caused by the adsorption layer is less than 5%, and the adsorption effect can be ignored. N2, CH4, and CO2 enter the transition flow regime under different pressure conditions; with gas extraction, the gas pressure decreases, and the difference in the gas flow characteristics of the three gases increases.
Feasibility analysis of early warning of sea fog within six hours for two harbors in the South China Sea
Authors: Zhou Mingsen , Huang Huijun , Lao Hanqiong , Cai Jingjiu , Wu Deping , Zhang Xinxin 
Published: September 2022

Sea fog significantly impacts harbor operations, at times even causing navigation to cease. This study examines two harbors in the north of the South China Sea, analyzing the feasibility of increasing each harbor’s sea fog early warning capability to 6 h in advance. Although the harbors are separated by only about 100 km, analysis of their backward trajectories reveals differences in the incoming flow and sea fog types. Concerning the types, at Xuwen harbor, warm advection fog represents 49.56% of the cases, cold advection representing 48.03%. At Zhanjiang harbor, 37.06% are warm advection fog, with 58.33% cold advection fog cases. We propose different monitoring and early warning schemes for the harbors. For Xuwen, we suggest eight visibility lidars located on the north and south sides of Qiongzhou Strait (two on the north, six on the south). Here, such a setup would give warning probabilities of sea fog of 87.50, 66.23, and 49.78% for advance times of 2, 3, and 4 h. For Zhanjiang, we suggest two visibility lidars and four buoys at the east side of the harbor. The corresponding warning probabilities are 83.77, 64.47, and 47.15% for the same advance times. For 5–6 h in advance, the early warning probabilities of both harbors drop quickly. We also suggest a flow chart for the early warning and monitoring scheme at each harbor.
Plasma tissue factor coagulation activity in post-acute myocardial infarction patients
Authors: Lim Xiong Chang , Yatim Siti Maryam J. M. , Chong Suet Yen , Wang Xiaoyuan , Tan Sock Hwee , Yang Xiaoxun , Chan Siew Pang , Richards A Mark , Charles Chris J. , Chan Mark Y. , Wang Jiong-Wei 
Published: September 2022

IntroductionCoagulation is involved in fibroproliferative responses following acute myocardial infarction (AMI). Left ventricular (LV) remodeling following AMI is closely associated with progression to heart failure. This study aims to assess the association between plasma tissue factor activity and LV remodeling in post-AMI patients.MethodsWe studied 228 patients with AMI and 57 healthy subjects. Patients with AMI were categorized into two age- and sex-matched groups: patients with adverse LV remodeling or reverse LV remodeling, defined by an increase or decrease, respectively, in LV end systolic volume by ≥15% over 6 months. TF activity was measured in plasma collected at baseline (within 72 hours of revascularization), 1 month and 6 months post-AMI. Multiple level longitudinal data analysis with structural equation (ML-SEM) model was used to assess the impact of various clinical variables on TF activity in post-AMI.ResultsPlasma TF activity in post-AMI patients at baseline (29.05 ± 10.75 pM) was similar to that in healthy subjects but fell at 1 month (21.78 ± 8.23, p&lt;0.001) with partial recovery by 6 months (25.84 ± 8.80, p&lt;0.001) after AMI. Plasma TF activity at 6 month post-AMI was better restored in patients with reverse LV remodeling than those with adverse LV remodeling (27.35 ± 7.14 vs 24.34 ± 9.99; p=0.009) independent of gender, age and relevant cardiovascular risk factors.ConclusionsPlasma TF activity decreased after AMI but was better restored at 6 months in patients with reverse LV remodeling. The clinical significance of changes in post-AMI plasma TF activity needs further investigation.
GnRH-agonist pretreatment in hormone replacement therapy improves pregnancy outcomes in women with male-factor infertility
Authors: Yu Juanjuan , Chen Peiqin , Luo Yifan , Lv Mu , Lou Liqun , Xiao Qimeng , Wang Luxia , Chen Juan , Bai Mingzhu , Zhang Zhenbo 
Published: September 2022

ObjectiveThis study aimed to examine the efficacy of HRT with gonadotropin-releasing hormone agonist (GnRH-a) pre-treatment in women with male-factor infertility who underwent a frozen embryo transfer (FET) programme.DesignBetween January 2016 and October 2020, 2733 women with male-factor infertility who underwent the HRT protocol as the endometrial preparation method were enrolled at two Reproductive Medicine Centres. Patients were divided into two groups based on whether they had GnRH-a pre-treatment before HRTs: the GnRHa-HRT group and the HRT group. The inverse probability of treatment weighting (IPTW) method was conducted to balance patient baseline characteristics between treatment cohorts to reduce selection bias. The live birth rate was considered regarded as the primary pregnancy outcome.ResultsMultivariate logistic regression adjusted for confounding factors, the GnRHa-HRT group showed a notably higher rate of live birth (OR 2.154, 95% CI 1.636~2.835, P&lt;0.001) when compared to the HRT group. Additionally, the rate of miscarriage was significantly lower in the GnRHa-HRT group. The GnRHa-HRT group had significantly higher rates of biochemical pregnancy, clinical pregnancy, multiple pregnancy, and term birth.ConclusionThe endometrial preparation protocol of HRT with GnRH-a pre-treatment could obviously increase the live birth rate for women with male-factor infertility undergoing the FET programme.
Day-3-embryo fragmentation is associated with singleton birth weight following fresh single blastocyst transfer: A retrospective study
Authors: Cai Jiali , Liu Lanlan , Chen Jinghua , Liu Zhenfang , Jiang Xiaoming , Chen Haixiao , Ren Jianzhi 
Published: September 2022

BackgroundPrevious studies have arguably associated poor embryo morphology with low birth weight in singletons following single embryo transfer. However, the association between birth weight and specific morphological features in the cleavage stage remains less known. The purpose of the study was to investigate whether morphological features of embryos at the cleavage stage affect birth weight following blastocyst transfer.MethodsThe single-center retrospective cohort study included 4,226 singletons derived from fresh single cleavage-stage embryo transfer (ET; n = 1,185), fresh single blastocyst transfer (BT; n = 787), or frozen-thawed single blastocyst transfer (FBT; n = 2,254) between 2016 and 2019. Morphological parameters including early cleavage, day-3 fragmentation, symmetry, blastomere number, and blastocyst morphology were associated with neonatal birth weight and birth weight z-score in multivariate regression models. The models were adjusted for maternal age, body mass index (BMI), parity, peak estradiol level, endometrial thickness, insemination protocol, female etiologies, order of transfer, mode of delivery, and year of treatment.ResultsAdjusted for confounders, day-3 fragmentation was the only morphological feature associated with birth weight and birth weight z-score, while early cleavage, symmetry, blastomere number, and blastocyst morphology were not. Day-3 fragmentation increased the birth weight in both the ET (115.4 g, 95% CI: 26.6–204.2) and BT groups (168.8 g, 95% CI: 48.8–288.8) but not in the FBT group (7.47 g, 95% CI: -46.4 to 61.3). The associations between birth weight and these morphological parameters were confirmed through birth weight z-score analyses. The adjusted odds of large for gestational age (LGA) and high birth weight were also significantly greater in singletons following the transfer of fragmented embryos in the BT group [odds ratio (OR) 3, 95% CI: 1.2–7.51 and OR 3.65, 95% CI: 1.33–10, respectively]. The presence of fragmentation at the cleavage stage also affected the association between the blastocyst morphology and birth weight. Inner cell mass grades were negatively associated with birth weight in blastocysts with day-3 fragmentation but not in blastocysts without.ConclusionsThe birth weight following blastocyst transfer was found to be positively associated with fragmentation at the cleavage stage. The data did not support the argument that transferring a poor-looking embryo may increase the risks of low birth weight. However, concerns for LGA infants remain.
The role of lipid traits in mediating the effect of body mass index on serum urate
Authors: Peng Liuqing , Jing Jiarui , He Simin , Wang Juping , Gao Xue , Wang Tong 
Published: September 2022

ObjectiveTo explore whether total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglyceride (TG) are mediators in the pathway of body mass index (BMI) on serum urate and determine the proportion of the mediation effect.MethodsThis study used observational and two-sample Mendelian randomization (MR) analyses to explore the mediation effects of TC, HDL, LDL, and TG in the pathway of BMI on serum urate. We determined the size and the extent to which these lipids mediate any effect of BMI on serum urate.ResultsObservational analysis results showed that HDL and TG can partially explain the association of BMI on serum urate, and the proportion of mediation effect was 10.2% and 8.9%, respectively. MR results demonstrated that TG has a causal effect on serum urate (β = 0.22, 95% CI: 0.15, 0.29; p = 2.28×10–10.) and its proportion of mediation effect was 14.1%. TC, HDL, and LDL are not the mediators in the pathway of BMI on serum urate in MR estimates.ConclusionTo a certain extent, TG mediates the effect of BMI on serum urate, and the risk of gout may be reduced by controlling both BMI and TG.
Association between subclinical hyperthyroidism and a PRKAR1A gene variant in Carney complex patients: A case report and systematic review
Authors: Wang Hongyang , Mao Min , Liu Dongfang , Duan Lian 
Published: September 2022

Background and ObjectivesIt is currently controversial whether subclinical hyperthyroidism is associated with PRKAR1A gene variants. We describe a man with subclinical hyperthyroidism and a PRKAR1A gene variant who was diagnosed with Carney complex (CNC), and we performed a systematic review of published studies to assess the association between PRKAR1A gene variants and the risk of subclinical hyperthyroidism.Design and MethodsThe PubMed, EMBASE, OVID, Science Direct, and gray literature electronic databases were searched for articles published from January 2002 to May 2021 using predefined keywords and inclusion and exclusion criteria. Data on thyroid function from selected studies were extracted and analyzed.ResultsWe identified a CNC patient with a subclinical hyperthyroidism phenotype combined with multiple components and genetic sequenced data. In a subsequent systematic review, twenty selected studies (14 case studies and 6 series studies) enrolling 23 individuals were included in the final analysis. The patient’s thyroid function data were qualitative in 11 cases and quantitative in 12 cases. The prevalence of subclinical hyperthyroidism in the CNC patients with a PRKAR1A gene variant, including our patient, was markedly higher than that in the normal population (12.5% vs. 2%)ConclusionsThe findings of this systematic review provide helpful evidence that PRKAR1A gene variants and subclinical hyperthyroidism are related and suggest that subclinical hyperthyroidism may be a neglected phenotype of PRKAR1A gene variants and a novel component of CNC patients.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO, identifier CRD42021197655.